LEP and Hepatic steatosis: Our objectives were to: (1) validate the RLD criteria in a European population, (2) characterize the relationship between leptin levels and MASLD prevalence, and (3) assess the potential utility of leptin as a biomarker for hepatic steatosis risk stratification in real-world clinical practice.